(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Skin Cancer
A research study of an investigational medication for the treatment of melanoma. Volunteers at least 18 who have histologically or cytologically confirmed unresectable Stage III b/c or Stage IV melanoma may be eligible. Research site located in Hartford, Conn.
More Information
Please see http://www.centerwatch.com/patient/studies/cat37.html.
-----
Stomach Discomfort
A research study of an investigational medication for the treatment of dyspepsia. Volunteers who have symptoms that occur during or after eating including an early sense of fullness with eating, mid- to upper-abdominal pain or discomfort, bloating, and possible nausea or vomiting may be eligible. Research site located in Oro Valley, Ariz.
More Information
Please see http://www.centerwatch.com/patient/studies/cat310.html.
-----
Multiple Sclerosis
A research study for multiple sclerosis patients to evaluate whether an investigational medication is effective in reducing the number of MRI lesions with a minimum number of side effects. Volunteers 18 to 55 who have been diagnosed with relapsing multiple sclerosis, with at least one relapse in the last two years, may be eligible. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat102.html.
-----
Copyright 2004 CenterWatch. All rights reserved.
